Central serous chorioretinopathy (CSCR) is the fourth most common retinopathy after age-related macular degeneration, diabetic retinopathy, and branch retinal vein occlusion. CSCR typically occurs in men in their 20s to 50s who exhibit acute or subacute central vision loss or distortion.

Central serous chorioretinopathy was defined as the presence of SRF involving the fovea on OCT, angiographic leakage on fluorescein angiography (FA) consistent with CSCR without evidence of choroidal neovascularization or other diseases, and an abnormal dilated choroidal vasculature consistent with CSCR on indocyanine green angiography.

2021年6月15日 · Central serous chorioretinopathy (CSCR) is a common retinal disorder that results in vision loss and alteration of visual function. 1 It is considered a pachychoroid disease, a category of diseases that includes polypoidal choroidal vasculopathy, pachychoroid neovasculopathy and pachychoroid pigment epitheliopathy. 2 Despite CSCR’s prevalence ...

2023年3月31日 · Choroidal imaging with enhanced-depth imaging–optical coherence tomography (EDI-OCT) is a clinical tool that may help differentiate CSR and nAMD. Patients with CSR commonly have increased choroidal thickness in affected as well as unaffected eyes. 5 - 7 Eyes with nAMD do not demonstrate increased choroidal thickness. 8 - 10.

2024年10月9日 · Central serous chorioretinopathy is when fluid builds up under the retina. This can distort vision. The fluid leakage comes from a layer of tissue under the retina, called the choroid. The layer of cells between retina and choroid …

2023年8月25日 · Central serous chorioretinopathy (CSCR) is a retinal disorder characterized by localized serous detachment of the macula with or without focal serous pigment epithelial detachment (PED). It is mostly seen in young men aged 20–45 years.[1]

中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy，CSCR)是以视网膜神经上皮浆液性脱离伴随脉络膜和视网膜色素上皮(retinal pigment epithelium，RPE)功能障碍为特点的疾病，一般具有自限性，但多数急性和慢性CSCR需进行治疗。目前主要治疗方式包括激光、手术 ...

Multimodal imaging techniques for CSC include optical coherence tomography (OCT) with enhanced depth imaging, fundus autofluorescence, fluorescein angiography, indocyanine green angiography, and OCT angiography.

2021年5月1日 · Advancement in multimodal imaging has been exploited, and a newer classification for CSCR has been proposed by the Central Serous Chorioretinopathy International Group. Concurrently, clinical trials have reported results of oral medication in CSCR, and newer treatment options are being explored.

2022年1月1日 · Central serous chorioretinopathy (CSCR) is a unique clinical entity characteristically seen in middle-aged males. 17 CSCR is six times more common in men, with average age at onset between 39 and 51 years. 17 Clinically it is characterized by diminution of central vision with metamorphopsia and central scotoma.